Cargando…

Correction to: Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review

Detalles Bibliográficos
Autores principales: Fusi-Rubiano, William, Blow, Rebecca R., Lane, Mark, Morjaria, Rupal, Denniston, Alastair K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054517/
https://www.ncbi.nlm.nih.gov/pubmed/32034688
http://dx.doi.org/10.1007/s40123-020-00231-3
_version_ 1783503212005818368
author Fusi-Rubiano, William
Blow, Rebecca R.
Lane, Mark
Morjaria, Rupal
Denniston, Alastair K.
author_facet Fusi-Rubiano, William
Blow, Rebecca R.
Lane, Mark
Morjaria, Rupal
Denniston, Alastair K.
author_sort Fusi-Rubiano, William
collection PubMed
description
format Online
Article
Text
id pubmed-7054517
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-70545172020-03-16 Correction to: Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review Fusi-Rubiano, William Blow, Rebecca R. Lane, Mark Morjaria, Rupal Denniston, Alastair K. Ophthalmol Ther Correction Springer Healthcare 2020-02-07 2020-03 /pmc/articles/PMC7054517/ /pubmed/32034688 http://dx.doi.org/10.1007/s40123-020-00231-3 Text en © The Author(s) 2020, corrected publication 2021 https://creativecommons.org/licenses/by-nc/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Correction
Fusi-Rubiano, William
Blow, Rebecca R.
Lane, Mark
Morjaria, Rupal
Denniston, Alastair K.
Correction to: Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
title Correction to: Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
title_full Correction to: Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
title_fullStr Correction to: Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
title_full_unstemmed Correction to: Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
title_short Correction to: Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
title_sort correction to: iluvien™ (fluocinolone acetonide 0.19 mg intravitreal implant) in the treatment of diabetic macular edema: a review
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054517/
https://www.ncbi.nlm.nih.gov/pubmed/32034688
http://dx.doi.org/10.1007/s40123-020-00231-3
work_keys_str_mv AT fusirubianowilliam correctiontoiluvienfluocinoloneacetonide019mgintravitrealimplantinthetreatmentofdiabeticmacularedemaareview
AT blowrebeccar correctiontoiluvienfluocinoloneacetonide019mgintravitrealimplantinthetreatmentofdiabeticmacularedemaareview
AT lanemark correctiontoiluvienfluocinoloneacetonide019mgintravitrealimplantinthetreatmentofdiabeticmacularedemaareview
AT morjariarupal correctiontoiluvienfluocinoloneacetonide019mgintravitrealimplantinthetreatmentofdiabeticmacularedemaareview
AT dennistonalastairk correctiontoiluvienfluocinoloneacetonide019mgintravitrealimplantinthetreatmentofdiabeticmacularedemaareview